SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001003642-18-000009
Filing Date
2018-01-09
Accepted
2018-01-09 09:14:08
Documents
21
Period of Report
2018-01-09
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ipxl-01x09x2018x701.htm 8-K 34646
2 EXHIBIT 99.1 exhibit991.htm EX-99.1 33490
3 exhibit991001.jpg GRAPHIC 120434
4 exhibit991002.jpg GRAPHIC 283890
5 exhibit991003.jpg GRAPHIC 242445
6 exhibit991004.jpg GRAPHIC 86458
7 exhibit991005.jpg GRAPHIC 112710
8 exhibit991006.jpg GRAPHIC 116762
9 exhibit991007.jpg GRAPHIC 103919
10 exhibit991008.jpg GRAPHIC 129895
11 exhibit991009.jpg GRAPHIC 96898
12 exhibit991010.jpg GRAPHIC 105908
13 exhibit991011.jpg GRAPHIC 96490
14 exhibit991012.jpg GRAPHIC 130448
15 exhibit991013.jpg GRAPHIC 83234
16 exhibit991014.jpg GRAPHIC 67650
17 exhibit991015.jpg GRAPHIC 86865
18 exhibit991016.jpg GRAPHIC 112622
19 exhibit991017.jpg GRAPHIC 50555
20 exhibit991018.jpg GRAPHIC 167178
21 exhibit991019.jpg GRAPHIC 145656
  Complete submission text file 0001003642-18-000009.txt   3286322
Mailing Address 30831 HUNTWOOD AVENUE HAYWARD CA 94544
Business Address 30831 HUNTWOOD AVENUE HAYWARD CA 94544 510-240-6000
IMPAX LABORATORIES INC (Filer) CIK: 0001003642 (see all company filings)

IRS No.: 650403311 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34263 | Film No.: 18517984
SIC: 2834 Pharmaceutical Preparations